Sang; Yingxia
Patent Applications and Registrations
Patent applications and USPTO patent grants for Sang; Yingxia.The latest application filed is for "compounds".
- Sang; Yingxia - Shanghai CN
| Patent | Date |
|---|---|
| Compounds for inhibiting LRRK2 kinase activity Grant 11,034,696 - Ren , et al. June 15, 2 | 2021-06-15 |
| Compounds App 20210130339 - REN; Feng ; et al. | 2021-05-06 |
| Substituted fused pyrazole compounds and their use as LRRK2 inhibitors Grant 10,975,081 - Ding , et al. April 13, 2 | 2021-04-13 |
| Compounds Grant 10,858,367 - Ding , et al. December 8, 2 | 2020-12-08 |
| LRRK2 inhibitors for the treatment of Parkinson's disease Grant 10,618,901 - Ding , et al. | 2020-04-14 |
| Compounds App 20200079777 - DING; Xiao ; et al. | 2020-03-12 |
| Compounds App 20200002323 - CUI; Haifeng ; et al. | 2020-01-02 |
| Compounds App 20190389850 - REN; Feng ; et al. | 2019-12-26 |
| Compounds For Inhibiting Lrrk2 Kinase Activity App 20190359618 - REN; Feng ; et al. | 2019-11-28 |
| Compounds App 20190359623 - DING; Xiao ; et al. | 2019-11-28 |
| Compounds App 20180354956 - Ding; Xiao ; et al. | 2018-12-13 |
| Compounds Grant 9,815,841 - Ding , et al. November 14, 2 | 2017-11-14 |
| 2,3-dihydroimidazol[1,2-C]pyrimidin-5(1-H)-one based ipoprotein-associated phospholipase A2 (Lp-PLA.sub.2) inhibitors Grant 9,708,330 - Wan , et al. July 18, 2 | 2017-07-18 |
| Compounds App 20170022204 - DING; Xiao ; et al. | 2017-01-26 |
| Compounds App 20170015668 - DING; Xiao ; et al. | 2017-01-19 |
| 2,3-dihydroimidazol[1,2-c]pyrimidin-5(1-h)-one Based Ipoprotein-associated Phospholipase A2 (lp-pla2) Inhibitors App 20150361082 - WAN; Zehong ; et al. | 2015-12-17 |
| Bicyclic [5,6] imidazo pyrimodone compounds for use in the treatment of diseases or conditions mediated by Lp-PLA.sub.2 Grant 9,051,325 - Wan , et al. June 9, 2 | 2015-06-09 |
| 2,3-dihydroimidazo[1, 2-c] pyrimidin-5(1 H)-one compounds use as LP-PLA2 inhibitors Grant 8,975,400 - Wan , et al. March 10, 2 | 2015-03-10 |
| Compounds App 20140213599 - WAN; Zehong ; et al. | 2014-07-31 |
| 2,3-DIHYDROIMIDAZO[1 ,2-c] PYRIMIDIN-5(1 H)-ONE COMPOUNDS USE AS LP-PLA2 INHIBITORS App 20140179715 - Wan; Zehong ; et al. | 2014-06-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 